MMJ Recs

NOVEMBER 17, 2023

It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions. Licensing fees, taxes, and other revenue sources associated with MMJ operations generate income that can be reinvested in public services, healthcare initiatives, and community development.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

United Patients Group

FEBRUARY 8, 2023

It’s no wonder that doctors are looking for new ways to treat patients with chronic pain without resorting to these highly addictive substances. Opioids are also prescribed to treat pain and other medical conditions such as coughs, diarrhea and muscle spasms. Cannabinoids may have potential in treating chronic pain.

Chronic Pain 105

Chronic Pain Cannabinoids Research and Development Patients 105

PrestoDoctor

SEPTEMBER 26, 2023

Research suggests that cannabis can affect various aspects of mental health , including mood, cognition, and behavior. It’s important to note that not everyone who uses cannabis will develop mental health issues. Research suggests that there is indeed a link between cannabis use and mental health issues.

Research and Development 105

Research and Development Chronic Pain Sleep Conditions 105

MGC Pharma

FEBRUARY 20, 2018

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.

Research and Development 100

Research and Development Clinical Trials Patients Chronic Pain 100

MMJ Recs

FEBRUARY 18, 2024

As society re-evaluates its stance on cannabis, a growing body of research is uncovering the therapeutic potential of this plant. These may include chronic pain, nausea and vomiting related to chemotherapy, muscle spasms, seizures, and mental health disorders.

Chronic Pain 52

Chronic Pain Marijuana Epilepsy Research and Development 52

Cannabis Law Report

NOVEMBER 10, 2021

– Multiple Contracts Awarded to Support the Development and Manufacturing of Envelta (NES100) – BERWYN, Pa.–(BUSINESS Envelta is Virpax’s endogenous enkephalin intranasal spray for acute and chronic pain, including pain associated with cancer. In October 2021, Virpax announced that a $1.87

Research and Development 52

Research and Development Chronic Pain Pharmaceutical Clinical Trials 52

United Patients Group

AUGUST 1, 2023

Alleviating Chronic Pain One of the most widely acknowledged benefits of medical cannabis is its ability to manage pain. The use of medical cannabis can help reduce inflammation, alleviate pain, and improve overall quality of life. This article delves deep into the undeniable benefits of medical cannabis.

Epilepsy 52

Epilepsy Sleep Chronic Pain Research and Development 52

Veriheal

MARCH 6, 2024

The HSS found strong scientific support regarding cannabis’ medically beneficial effects for conditions like anorexia , nausea, and chronic pain. The HSS also pointed out studies with weaker evidence suggesting cannabis can potentially help with conditions like PTSD , epilepsy , and anxiety.

Research and Development 62

Research and Development DEA Chronic Pain Business 62

Cannabis Law Report

NOVEMBER 15, 2021

Virpax” or the “Company”) (NASDAQ:VRPX), today announced its financial results for the three and nine months ended September 30, 2021, and other recent developments. “We Our lead product candidate is Envelta™, which utilizes MET to deliver enkephalin nanoparticles for acute and chronic pain including pain associated with cancer.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

LifeCannMD

SEPTEMBER 30, 2024

He is dedicated to science-based Medical Marijuana treatments to reduce pain and help you A Leader in Medical Marijuana Evaluations Fernando Fandiño-Sende, MD is a Double Board-Certified Cardiologist and Internal Medicine Doctor with more than 30 years of experience in the medical field.

Marijuana 52

Marijuana Research and Development Chronic Pain Conditions 52

MMJ Recs

JULY 5, 2024

Medical Uses of THC Let’s explore the diverse medical uses of THC, highlighting its efficacy in alleviating chronic pain, its comparison with traditional painkillers, its role in combating nausea and stimulating appetite, its potential benefits for neurological disorders, and its complex interaction with mental health conditions.

THC 52

THC Research and Development Chronic Pain Cannabinoids 52

The Herb Collective

AUGUST 1, 2023

Pain Reduction: Cannabis Indica is a natural choice for individuals enduring chronic pain. Its ability to aid in pain reduction has attracted patients and doctors alike, who appreciate the chemical compounds found in the plant that work to reduce inflammation.

Indica 87

Indica Blood Pressure Epilepsy Sleep 87

United Patients Group

JULY 29, 2024

This makes it particularly useful for managing chronic pain and inflammation, which are common issues faced by many individuals. For instance, incorporating CBD oil into your daily routine might provide long-term relief from persistent pain without the psychoactive effects associated with THC.

Research and Development 52

Research and Development Strains Chronic Pain Medicine 52

MMJ Recs

MAY 25, 2024

Medical marijuana has been a hot topic over the years – from the stigma it surrounds the cannabis industry to its legalization in US states and its research and use for treating various ailments. Chronic pain conditions such as arthritis and neuropathy often find relief through ECS modulation, reducing inflammation and pain perception.

Patients 105

Patients Marijuana Cannabinoids Chronic Pain 105

Cannabis Law Report

OCTOBER 6, 2021

Under the terms of this agreement, Sinclair Research will perform preclinical animal studies including method, dosage and toxicity as part of the enabling trials for an Investigational New Drug Application (“IND”) for AnQlar, as required by the U.S. Food and Drug Administration (“FDA”). The studies are expected to begin in January of 2022.

Research and Development 52

Research and Development Clinical Trials Pharmaceutical Chronic Pain 52

PrestoDoctor

OCTOBER 13, 2023

Marinol, also known as Dronabinol, is a medication used to treat a variety of conditions, including nausea and vomiting caused by chemotherapy, loss of appetite and weight loss in people with HIV/AIDS, as well as chronic pain. However, it’s important to note that the pain-relieving properties of Marinol are still being studied.

THC 98

THC Chronic Pain Treatment Conditions 98

Cannabis Law Report

JANUARY 18, 2022

Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing product candidates for pain management, CNS disorders, and anti-viral indications, reported positive results of four preclinical dermal safety studies for Epoladerm™ (diclofenac epolamine). Well-tolerated with No Serious Adverse Findings. BERWYN, Pa.–(BUSINESS

Safety 52

Safety Chronic Pain Research and Development Pharmaceutical 52

MMJ Recs

NOVEMBER 10, 2021

Medical marijuana has been used to help treat a variety of health ailments, from conditions such as epilepsy to chronic pain disorders. This leads to the common symptoms of the disease – pain, stiffness, decreased range of motion, and swelling. Image by Kindel Media on Pexels : Do edibles help with arthritis pain?

Chronic Pain 52

Chronic Pain Marijuana Research and Development Conditions 52

Veriheal

MAY 31, 2022

With a worsening opioid situation and an emerging acceptance of medical cannabis, the Lone Star State has a unique opportunity to develop a successful medical marijuana (MMJ) program for its millions of residents battling chronic pain and numerous other conditions. A Better Alternative for Chronic Pain.

Programs 52

Programs Chronic Pain Treatment Conditions 52

MMJ Recs

JUNE 23, 2024

Their progressive stance not only affords relief to those grappling with chronic pain, debilitating illnesses, and neurological disorders but also underscores a commitment to patient-centric care and holistic wellness. Pennsylvania is among the states that have embraced the medicinal use of cannabis.

Conditions 52

Conditions Marijuana Patients Chronic Pain 52

Cannabis Law Report

MAY 3, 2022

Acute pain usually occurs suddenly and lasts less than a few weeks. However, chronic pain is ongoing, usually longer than three months. Pain relief treatments range from over-the-counter medications such as ibuprofen or acetaminophen to prescription medications such as muscle relaxers or opioids. What is Delta 8?

Chronic Pain 52

Chronic Pain Research and Development THC Cannabinoids 52

MMJ Recs

JUNE 25, 2024

Cannabis consumption for medical purposes has gained widespread acceptance in recent years, thanks to growing research supporting its efficacy in alleviating symptoms associated with numerous medical conditions. If you experience severe or persistent symptoms, consult with a healthcare provider.

Consumption 52

Consumption Conditions Chronic Pain Tincture 52

Veriheal

OCTOBER 19, 2022

Warastuti, the mother of Pika Sasi Kirana, is actively lobbying for legal access and research into the plant alongside her daughter’s father, Sunarta. pounds) at birth, Pika developed into a healthy young toddler and progressed to kindergarten without any problems. Weighing 3.4 kilograms (7.5

Legalization 104

Legalization Research and Development Chronic Pain Treatment 104

Cannabis Law Report

NOVEMBER 24, 2019

Recommendations for research. Chronic pain. Severe treatment-resistant epilepsy. Chronic pain. Do not offer the following to manage chronic pain in adults: nabilone. Do not offer CBD to manage chronic pain in adults unless as part of a clinical trial. Recommendations. Spasticity.

Medicine 59

Medicine Chronic Pain Research and Development Treatment 59

United Patients Group

FEBRUARY 2, 2023

The ECS has been studied for its role in many diseases including cancer , epilepsy, chronic pain and multiple sclerosis (MS). For example, if your insomnia is due to pain or anxiety, cannabis can help you get some restful sleep.

Blood Pressure 105

Blood Pressure Sleep Chronic Pain Digestion 105

United Patients Group

OCTOBER 25, 2023

While the risk of addiction to medical marijuana is relatively low compared to other substances like opioids, a small percentage of users may develop Cannabis Use Disorder, a condition characterized by excessive use, dependence, and negative impacts on daily life. What Conditions Can Medical Marijuana Treat?

Marijuana 105

Marijuana Patients Research and Development Edibles 105

United Patients Group

APRIL 18, 2023

However, there are still many myths about cannabis that persist despite being debunked by medical professionals and researchers alike. For example, if you have chronic pain and want relief from muscle spasms and stiffness in your joints, then an indica strain may be best for you. Myth: Cannabis is just a drug.

Research and Development 116

Research and Development Indica Treatment Conditions 116

MMJ Recs

FEBRUARY 3, 2021

THC can offer medical relief from the symptoms of several ailments and conditions, including: Chronic pain Insomnia Glaucoma Loss of appetite Nausea Anxiety Autism. Recent studies have found that the use of CBD oil in cancer helped to reduce nausea, vomiting, and pain in patients undergoing chemotherapy treatments.

Cannabinoids 52

Cannabinoids Patients Blood Pressure Chronic Pain 52

Medicinal Marijuana Association

FEBRUARY 11, 2024

These compounds have been linked to pain relief, reduced inflammation, and improved mood regulation. By interacting with the endocannabinoid system, cannabinoids can help manage chronic pain conditions, alleviate symptoms of anxiety and depression, and even enhance appetite.

Cannabinoids 52

Cannabinoids Chronic Pain Blood Pressure Research and Development 52

Cannabis Law Report

JANUARY 4, 2022

Virpax is developing branded product candidates for non-addictive pain management and neurological disorders using its proprietary technologies to optimize and target drug delivery. Epoladerm™ is a topical diclofenac spray film formulation being developed to manage osteoarthritis pain. Wainwright & Co.

Pharmaceutical 52

Pharmaceutical Research and Development Chronic Pain Events 52

Cannabis Law Report

AUGUST 2, 2021

Study Results Indicate SCI-160 Has A Significant Analgesic Effect on Acute and Chronic Pain. ” A study conducted by The G4 Alliance reports 300 million surgical procedures are performed annually, with an estimated 60 to 70% of patients experiencing moderate to severe pain just after 24 hours of surgery. after injection.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

MMJ Recs

MARCH 28, 2024

From researching qualified doctors to scheduling appointments and discussing treatment options, we provide practical insights and tips to help patients confidently navigate this journey. Patients should research and familiarize themselves with these professionals to ensure they receive appropriate guidance and care.

Patients 52

Patients Treatment Research and Development Therapy 52

The Joint Blog

JUNE 4, 2021

Those state laws allow medical marijuana to be used to treat ailments like Alzheimer’s, cancer, epilepsy, Crohn’s disease, seizures, hepatitis C and a host of others. The United States Food and Drug Administration (FDA) has only cannabis use to treat two rare and severe forms of epilepsy: Dravet syndrome and Lennox-Gastaut syndrome.

Conditions 32

Conditions Chronic Pain Marijuana Research and Development 32

FloridaMarijuana.net

OCTOBER 18, 2018

A 2006 edition of Current Pharmacology published an article titled: “Role of the Cannabinoid System in Pain Control and Therapeutic Implications for the Management of Acute and Chronic Pain Episodes”. If this system consistently has a shortage in the endocannabinoid system, disease or illness could develop. Parkinson’s.

Cannabinoids 169

Cannabinoids THC Chronic Pain Patients 169

Cannabis Law Report

APRIL 4, 2019

House of Hemp hope to build on existing medical research and further explore the potential of cannabis as a healing plant. Limited evidence suggests cannabis can reduce nausea and vomiting during chemotherapy, improve appetite in people with HIV/AIDS, and reduce chronic pain and muscle spasms.

Cultivation 40

Cultivation Research and Development Chronic Pain Data 40

MMJ Recs

DECEMBER 22, 2023

Historically, marijuana was vilified and classified as a Schedule I controlled substance, which hindered both research and public acceptance. One of the key drivers of this shift is the increasing body of scientific research highlighting the medical properties of cannabinoids, the active compounds in marijuana.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

OCTOBER 1, 2021

(“Virpax” or the “Company”) (NASDAQ:VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications, today announced that Chairman and CEO Anthony P. Probudur™ is a single injection liposomal bupivacaine formulation being developed to manage post-operative pain.

Research and Development 52

Research and Development Pharmaceutical Clinical Trials Chronic Pain 52